Security Snapshot

Quipt Home Medical Corp. - Common Shares (QIPT) Institutional Ownership

CUSIP: 74880P104

13F Institutional Holders and Ownership History from Q1 2021 to Q1 2026

13F reference period

n/a

Institutions Reporting

Shares (Excl. Options)

n/a

Price

$3.64

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Shares outstanding
44,001,487
SEC-reported price per share
$3.64
Insider filing price
$3.64
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • QIPT - Quipt Home Medical Corp. - Common Shares is tracked under CUSIP 74880P104.
  • 13F reference-period holder data is not available.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder data for the Q2 2026 reference period is not available.
  • Available periods remain in the history table; they do not substitute for the headline period.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

74880P104

13F reference period

n/a

13F holders

13D/G owners

4

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
4
Security
QIPT
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Lakeview Opportunity Fund LLC 8% $9,044,115 3,465,178 Lakeview Opportunity Fund LLC 31 Oct 2025
Claret Asset Management Corp 7.3% -30% $11,449,847 -$4,421,490 3,225,309 -28% Claret Asset Management Corporation 31 Dec 2025
GLAZER CAPITAL, LLC 5.6% $8,752,372 2,476,409 Glazer Capital, LLC 08 Jan 2026
Philotimo Fund, LP 4.4% -36% $4,092,717 -$2,202,710 1,930,527 -35% Kanen David 20 May 2025

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
21
Headline period
n/a
Rows shown
1-21 of 21
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 0 $0 -$63,664,617 $3.64 0
2025 Q4 19,660,086 $69,403,088 +$1,029,811 $3.53 70
2025 Q3 20,935,971 $54,686,095 +$822,374 $2.61 59
2025 Q2 20,910,676 $37,439,271 -$11,284,731 $1.79 74
2025 Q1 25,306,219 $58,921,860 -$7,361 $2.33 87
2024 Q4 23,900,546 $72,868,949 +$3,561,465 $3.05 92
2024 Q3 22,735,923 $66,278,287 +$6,002,601 $2.92 91
2024 Q2 20,527,909 $66,131,637 +$3,267,770 $3.22 87
2024 Q1 18,796,492 $82,150,697 +$5,954,179 $4.37 79
2023 Q4 18,103,721 $92,182,343 -$3,591,149 $5.09 83
2023 Q3 18,808,213 $95,868,798 +$7,877,309 $5.09 87
2023 Q2 17,233,237 $92,134,619 +$21,492,644 $5.34 90
2023 Q1 13,041,001 $91,505,194 +$20,883,773 $7.01 67
2022 Q4 10,054,727 $47,162,293 +$3,643,311 $4.71 35
2022 Q3 9,286,985 $38,491,288 +$10,178,184 $4.16 35
2022 Q2 6,820,322 $31,346,169 +$4,055,057 $4.62 31
2022 Q1 5,944,197 $26,217,682 -$2,613,131 $4.39 29
2021 Q4 6,367,419 $35,685,500 +$3,068,532 $5.61 38
2021 Q3 5,810,948 $36,401,374 +$5,887,664 $6.29 33
2021 Q2 4,879,915 $30,385,060 +$30,312,060 $6.26 26
2021 Q1 37,700 $73,000 +$73,000 $1.94 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .